Gene and cell therapies Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
18:07
Jan 29
Jan 29
Biotech gene/cell therapy approvals accelerate
Kennedy says the administration approved more gene and cell therapies last month than ever before and is creating a safe and encouraging ecosystem for biotech so China does not steal the industry.
MED
About Gene and cell therapies Investor Commentary
Across the available history and selected sources, Buzzberg tracks Gene and cell therapies across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Robert F. Kennedy Jr..